p16(INK4A) promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells

Blood

Volumn 90, Issue 10, 1997, Pages 4106-4115

  Urashima, Mitsuyoshi ^b   DeCaprio, James A ^b   Chauhan, Dharminder ^b   Teoh, Gerrard ^b   Ogata, Atsushi ^b   Treon, Steven P ^b   Hoshi, Yasutaka ^b   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DEXAMETHASONE; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ETIOLOGY; GENE DELETION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TEMPERATURE SENSITIVE MUTANT; ACUTE LYMPHOCYTIC LEUKEMIA; AMINO ACID SEQUENCE; CELL CULTURE; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETICS; MOLECULAR GENETICS; PATHOLOGY; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; APOPTOSIS; CELL DIFFERENTIATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; GENES, P16; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MOLECULAR SEQUENCE DATA; TUMOR CELLS, CULTURED;

EID: 0030612734     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4106     Document Type: Article

References (46)

1. Hirama T, Koeffler HP: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
2. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704, 1993
3. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753, 1994
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stocken E, Day III RS, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436, 1994
5. de Vos S, Miller CW, Takeuchi S, Gombart AF, Cho SK, Koeffler HP: Alteration of CDKN2 (p16) in non-small cell lung cancer. Genes Chromosomes Cancer 14:164, 1995
6. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J, Sidransky D: High frequency of p16(CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56:3630, 1996
7. INK4 function. Nat Genet 10:114, 1995
8. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA, Dracopoli NC: Germline p16 mutations in familial melanoma. Nat Genet 8:15, 1994
9. INK4 gene inactivation in acute lymphoblastic leukemia. Blood 85:3431, 1995
10. Takeuchi S, Bartram CR, Seriu T, Miller CW, Tobles A, Janssen WG, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi I, Koeffler PH: Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 86:755, 1995
11. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H: Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 84:2431, 1994
12. INK4B gene deletions in primary leukemias. Blood 86:311, 1995
13. Dreyling MH, Bohlander SK, LeBeau MM, Olopade OI: Refined mapping of genomic rearrangement involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies. Blood 86:1931, 1995
14. Fizzotti M, Cimino G, Pisegna S, Alimena G, Quartnarone C, Mandelli F, Pelicci PG, Coco FL: Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85:2685, 1995
15. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Feuauz P: p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 85:657, 1995
16. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP: Homozygous deletion of the p15(MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 85:2699, 1995
17. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27, 1996
18. INK4B tumor suppressor and immunoglobulin heavy chain genes: TGF β/IL-7 inhibitory signaling mechanism. Leukemia 10:1576, 1996
19. Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ: Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55:6200, 1995
20. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJS: Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 55:1351, 1995
21. Liggett WH Jr, Sewell DA, Rocco J, Ahrendt SA, Koch W, Sidransky D: p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 56:4119, 1996
22. Stone S, Dayananth P, Kamb A: Reversible, p16-mediated cell cycle arrest as protection from chemotherapy. Cancer Res 56:3199, 1996
23. Lux SE, John KM, Benne V: Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344:36, 1990
24. Reymond A, Schmidt S, Simanis V: Mutations in the cdc10 start gene of Schizosaccharomyces pombe implicate the region of homology between cdc10 and SW16 as important for p85cdc10 function. Mol Gen Genet 234:449, 1992
25. Morgenstern JP, Land H: Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587, 1990
26. Kingston RE, Chen CA, Okayama H: Introduction of DNA into mammalian cells, in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struth K (eds): Current Protocols in Molecular Biology. New York, NY, Wiley, 1993, p 2.03
27. Urashima M, Ogata A, Chauhan D, Vidriales M, Teoh G, Hoshi Y, Schlossman RL, DeCaprio JA, Anderson KC: Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 88:2219, 1996
28. Urashima M, Ogata A, Chauhan D, Hatziyanni M, Vidriales MB, Dedera DA, Schlossman RL, Anderson KC: Transforming growth factor β1: Differential effects on multiple myeloma versus normal B cells. Blood 87:1928, 1996
29. WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon γ in multiple myeloma cells. Blood 90:279, 1997
30. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson KC: CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903, 1995
31. Urashima M, Chauhan D, Hatzianni M, Ogata A, Hollenbaugh D, Aruffo A, Anderson KC: CD40 ligand triggers interleukin-6-mediated B cell differentiation. Leuk Res 20:507, 1996
32. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC: Interleukin-6 inhibits Fasinduced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89:227, 1997
33. Boice JA, Fairman R: Structural characterization of the tumor suppressor p16, an ankyrin-like repeat protein. Protein Sci 5:1776, 1996
34. Zhang B, Peng Z: Defective folding of mutant p16(INK4) proteins encoded by tumor-derived alleles. J Biol Chem 271:28734, 1996
35. CDKN2 associated with familial melanoma. Mol Cell Biol 16:3844, 1996
36. CDKN2/INK4A. Curr Biol 6:84, 1996
37. Yang R, Serrano M, Slater J, Leung E, Koeffler HP: Analysis of p16INK4a and its interaction with CDK4. Biochem Biophys Res Commun 218:254, 1996
38. INK4a tumor suppressor protein. Cancer Res 55: 2503, 1995
39. Serrano M, Gomez-Lahoz E, DePinho A, Beach D, Bar-Sagi D: Inhibition of Ras-induced proliferation and cellular transformation by p16INK4. Science 267:249, 1995
40. Wang J, Walsh K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359, 1996
41. WAF1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16:1335, 1996
42. Wang J, Guo K, Wills KN, Walsh K: Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res 57:351, 1997
43. Haas-Kogan DA, Kogan D, Levi P, Dazin A, Tang T, Fung Y-KT, Israel MA: Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 14:461, 1995
44. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288, 1992
45. Iwata M, Ohoka Y, Kuwata T, Asada A: Regulation of T cell apoptosis via T cell receptors and steroid receptors. Stem Cells 14:632, 1996
46. Smets LA, van den Berg JD: Bcl-2 expression and glucocorticoid-induced apoptosis of Ieukemic and lymphoma cells. Leuk Lymphoma 20:199, 1996